We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+7.1%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
+$214M
(+8.6%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
36.8%
Holding
3,484
New
256
Increased
1,490
Reduced
872
Closed
231
Avg Time Held Equity + Options
2.8
years
Top 10 Avg Time Held Equity + Options
2.2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
2.2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$29.6M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$14.8M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$14.3M |
| 4 |
Payoneer
PAYO
|
+$13.7M |
| 5 |
Doximity
DOCS
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$17.7M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$15.8M |
| 3 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$10.4M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$8.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 16.87% |
| 3 | Financials | 7.26% |
| 4 | Healthcare | 6.41% |
| 5 | Consumer Discretionary | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Seritage Growth Properties
SRG
$91.2M
| – | – |
-180
| Closed | -$3K | – |
|
3277
Scully Royalty
SRL
$72.3M
| $0 | ﹤0.01% |
34
+2
| +6% | +$20 |
2021 Q1
3 quarters
|
|
3278
Scholar Rock
SRRK
$4.82B
| – | – |
-19
| Closed | -$1K | – |
|
3279
Stratasys
SSYS
$617M
| – | – |
-8
| Closed | – | – |
|
3280
Tarsus Pharmaceuticals
TARS
$3.38B
| – | – |
-44
| Closed | -$1K | – |
|
3281
Alaunos Therapeutics
TCRT
$5.26M
| – | – |
-20
| Closed | -$5K | – |
|
|
TEAF
3282
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
| $0 | ﹤0.01% |
+25
| New | +$363 |
2021 Q4
0 quarters
|
|
3283
Telos
TLS
$312M
| – | – |
-2,210
| Closed | -$63K | – |
|
3284
Transmedics
TMDX
$2.62B
| $0 | ﹤0.01% |
+12
| New | +$301 |
2021 Q4
0 quarters
|
|
3285
Turning Point Brands
TPB
$1.16B
| – | – |
-25
| Closed | -$1K | – |
|
3286
TPG RE Finance Trust
TRTX
$433M
| $0 | ﹤0.01% |
+31
| New | +$395 |
2021 Q4
0 quarters
|
|
3287
DELISTED
Trinseo
TSE
| $0 | ﹤0.01% |
+6
| New | +$325 |
2021 Q4
0 quarters
|
|
3288
DELISTED
Tile Shop Holdings
TTSH
| $0 | ﹤0.01% |
5
| – | – |
2021 Q3
1 quarter
|
|
3289
Twist Bioscience
TWST
$9.82B
| $0 | ﹤0.01% |
4
-97
| -96% | -$9.96K |
2021 Q2
2 quarters
|
|
3290
Ternium
TX
$11.5B
| – | – |
-175
| Closed | -$7K | – |
|
3291
DELISTED
Unity Biotechnology
UBX
| – | – |
-1
| Closed | – | – |
|
3292
Uranium Energy
UEC
$3.82B
| $0 | ﹤0.01% |
+91
| New | +$350 |
2021 Q4
0 quarters
|
|
3293
Universal Electronics
UEIC
$64.2M
| $0 | ﹤0.01% |
+7
| New | +$290 |
2021 Q4
0 quarters
|
|
3294
UroGen Pharma
URGN
$1.79B
| $0 | ﹤0.01% |
47
| – | – |
2020 Q2
6 quarters
|
|
3295
Veracyte
VCYT
$3.5B
| $0 | ﹤0.01% |
+4
| New | +$177 |
2021 Q4
0 quarters
|
|
3296
Vishay Precision Group
VPG
$847M
| $0 | ﹤0.01% |
2
-8
| -80% | -$286 |
2016 Q4
20 quarters
|
|
3297
Vera Bradley
VRA
$162M
| – | – |
-44
| Closed | – | – |
|
3298
Vroom Inc
VRM
$46.8M
| – | – |
0
| – | -$1K |
2021 Q2
2 quarters
|
|
|
VRNA
3299
DELISTED
Verona Pharma
VRNA
| – | – |
-2,000
| Closed | -$11K | – |
|
3300
Vanguard Russell 2000 Growth ETF
VTWG
$1.37B
| – | – |
-8
| Closed | -$2K | – |
|
Similar funds
Parallel Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Parallel Advisors held 3,484 positions worth $2.69B, up 8.6% from $2.48B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q4 2021 filing shows 256 new, 1,490 increased, 872 reduced and 231 closed positions. Its largest new stake was Payoneer: 1,784,455 shares worth $13.1M. The largest sale was iShares US Treasury Bond ETF, an estimated $17.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q4 2021 buy was Payoneer: 1,784,455 shares worth $13.1M.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $29.6M increase.
- Parallel Advisors's biggest Q4 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $17.7M.
- Parallel Advisors fully exited FTAC Olympus Acquisition Corp. Class A Ordinary Shares in Q4 2021, selling an estimated $15.5M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.69B portfolio in Q4 2021.
- Parallel Advisors opened 256 new positions and closed 231 in Q4 2021.
- Parallel Advisors's portfolio value rose 8.6% quarter-over-quarter to $2.69B.
Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.